Back pain device group Mainstay Medical raises $108m
Back pain device group Mainstay Medical raises $108m Funding will drive commercialisation of Reactiv8 in critical US market Tue, Feb 16, 2021, 13:00 Updated: Tue, Feb 16, 2021, 18:24 Irish company Mainstay Medical has developed a device to address chronic lower back pain Your Web Browser may be out of date. If you are using Internet Explorer 9, 10 or 11 our Audio player will not work properly. Irish company Mainstay Medical, which has developed a device to address chronic lower back pain, has raised $108 million(€89 million) to commercialise it in the US market. Mainstay, whi...
Source: irishtimes.com